MEITAV INVESTMENT HOUSE LTD (MTAV)
Private offering
Private offering
Dormant shares
Events and transactions
Dividend in kind
dividend
Management and officers – staffing as of 27.3.26
The company’s liability position as of 31.12.25, by maturity dates
Periodic and annual report for 2025
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million
Groupe Colabor Inc. fait le point sur son processus de vente et de sollicitation d’investissements